Table 2.
Baseline scores and within group changes from baseline to post-treatment assessment in physical performance, physical function, and health-related quality of life dimensions in adult and older patients receiving home-based physiotherapy services in Trondheim Municipality
| Total sample (n = 603) | n | Regular physiotherapy (n = 409) | n | Reablement (n = 132) | n | Early Intervention (n = 62) | n | Between group difference p-value1 | |
|---|---|---|---|---|---|---|---|---|---|
| Short Performance Physical Battery (0–12, higher score indicate better performance) | |||||||||
| Baseline, mean (SD) | 6.3 (3.0) | 373 | 5.6 (2.8) | 200 | 5.5 (2.6) | 113 | 7.9 (2.7) | 60 | < 0.001 |
| Post-treatment, mean (SD) | 7.1 (2.7) | 130 | 7.2 (2.5) | 66 | 6.6 (2.7) | 43 | 8.5 (2.8) | 19 | 0.04 |
| Change, mean (95 % CI) | 0.9 (0.6 to 1.1) | 128 | 1.0 (0.7 to 1.4) | 66 | 0.8 (0.4 to 1.3) | 43 | 0.4 (-0.2 to 1.0) | 19 | 0.25 |
| Patient Specific Functional Scale (0–10, higher score indicate better function) | |||||||||
| Baseline, mean (SD) | 3.6 (2.8) | 431 | 3.3 (2.9) | 298 | 4.1 (2.5) | 90 | 4.6 (2.4) | 43 | < 0.001 |
| Post-treatment, mean (SD) | 6.1 (3.2) | 217 | 6.1(3.3) | 153 | 5.8 (3.2) | 33 | 6.4 (2.7) | 31 | 0.75 |
| Change, mean (95 % CI) | 2.3 (1.8 to 2.8) | 217 | 2.5 (1.9 to 3.2) | 153 | 1.8 (0.5 to 3.1) | 33 | 1.7 (0.8 to 2.6) | 31 | 0.34 |
| Health related Quality of Life, EQ-5D (0–1, higher score indicate better quality of life | |||||||||
| Baseline, mean (SD) | 0.46 (0.22) | 551 | 0.41(0.22) | 383 | 0.50 (0.15) | 110 | 0.59 (0.19) | 58 | < 0.001 |
| Post-treatment, mean (SD) | 0.56 (0.21) | 380 | 0.54 (0.23) | 190 | 0.60 (0.16) | 45 | 0.61 (0.17) | 45 | 0.04 |
| Change, mean (95 % CI) | 0.10 (0.07 to 0.12) | 268 | 0.11 (0.08 to 0.14) | 183 | 0.10 (0.06 to 0.14) | 43 | 0.04 (-0.01 to 0.09) | 42 | 0.11 |
| EQ-5D Mobility | |||||||||
| Baseline, median (IQR) | 3 (2–3) | 554 | 3 (2–4) | 388 | 2 (2–3) | 58 | 2 (2-2.5) | 108 | < 0.001 |
| Post-treatment, median (IQR) | 2 (1–3 | 286 | 2 (1–3)* | 197 | 2 (1–3)* | 45 | 2 (1–2) | 44 | 0.13 |
| EQ-5D Personal care | |||||||||
| Baseline, median (IQR) | 2 (1–2) | 553 | 2 (1–3) | 387 | 1 (1–2) | 58 | 1 (1–1) | 108 | < 0.001 |
| Post-treatment, median (IQR) | 1 (1–2) | 290 | 1 (1–2)* | 197 | 1 (1–2)* | 45 | 1 (1-1.5) | 48 | 0.002 |
| EQ-5D Usual activities | |||||||||
| Baseline, median (IQR) | 3 (2–4) | 552 | 3 (2–4) | 386 | 2.5 (2–3) | 58 | 2 (1–2) | 108 | < 0.001 |
| Post-treatment, median (IQR) | 2 (1–3) | 289 | 2 (2–3)* | 196 | 2 (1–2)* | 45 | 2 (1–2) | 48 | < 0.001 |
| EQ-5D Pain/discomfort | |||||||||
| Baseline, median (IQR) | 2 (2–3) | 554 | 3 (2–3) | 388 | 2 (2–3) | 58 | 2 (1.5-3) | 108 | 0.08 |
| Post-treatment, median (IQR) | 2 (1–3) | 285 | 2 (1–3)* | 195 | 2 (1-2.5)* | 44 | 2 (2–3) | 46 | 0.68 |
| EQ-5D Anxiety/depression | |||||||||
| Baseline, median (IQR) | 2 (1–2) | 552 | 2 (1–2) | 386 | 2 (1–2) | 58 | 1 (1–2) | 108 | 0.42 |
| Post-treatment, median (IQR) | 1 (1–2) | 283 | 1 (1–2)* | 193 | 1.5 (1–2) | 44 | 1 (1–2) | 46 | 0.69 |
CI confidence interval, EQ-5D EuroQol health-related quality of life questionnaire
1p-value from analysis of variance or chi-square test
*p-value < 0.05; Wilcoxon signed rank test